This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Genomic Characterization

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Genomic Characterization Means

Genomic characterization, also called genomic profiling or biomarker testing, is a laboratory method that looks closely at the genes in cancer cells. It uses samples of tumor tissue, blood, or other body fluids to find changes or mutations in the DNA of the cancer. These changes can help doctors understand how the cancer started, how it might behave, and which treatments might work best. This testing is done on both solid tumors (like breast or lung cancer) and blood cancers (like leukemia).

Why Genomic Characterization Matters in Cancer Care

Each person’s cancer is unique, with its own pattern of genetic changes. Genomic characterization helps identify these changes, which can influence how the cancer grows and responds to treatment. Some treatments, such as targeted therapies or immunotherapies, are designed to work only if certain genetic changes are present. By knowing the genetic makeup of the cancer, doctors can choose treatments that are more likely to be effective and avoid those that may not help. This approach is part of precision medicine, which aims to tailor cancer care to the individual’s specific disease.

What Patients Might See or Hear About Genomic Characterization

If your doctor suggests genomic characterization, they may explain that this test looks for specific changes in your cancer’s genes. You might hear other names for the test, such as tumor testing, tumor genetic testing, molecular testing, or somatic testing. The results could influence your treatment plan, including the possibility of using drugs approved for other cancer types if your cancer shares the same genetic changes. Sometimes, genomic characterization results are used to find clinical trials that match your cancer’s genetic profile.

Where Genomic Characterization Appears in Cancer Care

You may see the term in your medical records, test reports, treatment plans, or when discussing clinical trials. It is often mentioned when cancer has spread or returned after treatment (advanced cancer). The test results might be part of a companion diagnostic, meaning the test is paired with a specific treatment designed to target the genetic change found.

What Genomic Characterization Does Not Mean

It is important to know that genomic characterization is not the same as inherited genetic testing. It does not tell you if you were born with a higher risk of cancer. Instead, it looks at changes that happened in the cancer cells themselves. Also, having a genetic change in your cancer does not guarantee that a particular treatment will work, but it helps guide treatment decisions.

How Doctors Use Genomic Characterization

Doctors use genomic characterization to help diagnose the cancer more precisely, plan treatment, and sometimes monitor how well treatment is working. It can also help identify patients who might benefit from newer treatments or clinical trials that focus on specific genetic changes. This testing is especially common for cancers that are advanced or have not responded to standard treatments.

Common Questions to Ask Your Care Team

If genomic characterization is recommended, you might ask: What specific changes are you looking for? How will the results affect my treatment options? Are there clinical trials I could join based on my test results? How is this test different from genetic testing for inherited cancer risk? What are the costs and how long will it take to get results?

Understanding the Term in Context

Genomic characterization may be called by several names, so comparing the wording in your test report or medical documents can help avoid confusion. Remember that this entry is for education and does not replace advice from your healthcare team. If you see this term in your records, the best next step is to ask your doctor or nurse what it means for your specific situation.

Next Steps for Patients and Caregivers

If genomic characterization is part of your cancer care, talk openly with your healthcare team about what the test involves and how it might influence your treatment. Understanding your cancer’s genetic changes can empower you to make informed decisions and explore all available options, including clinical trials. Always ask for clear explanations and support as you navigate your care.

Sources

Public source information used for this glossary entry includes: